Sebastian Grosicki: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih, Fraser, Graeme, Silva, Rodrigo Santucci, Grosicki, Sebastian, Pristupa, Aleksander, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L, Dilhuydy, Marie-S

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 588 KB

english, 2015

2

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

Cramer, Paula, Fraser, Graeme, Santucci-Silva, Rodrigo, Grosicki, Sebastian, Dilhuydy, Marie-Sarah, Janssens, Ann, Loscertales, Javier, Rule, Simon, Goy, Andre, Traina, Shana, Chan, Eric K. H., Diels,

Journal:

Leukemia and Lymphoma

Year:

2018

Language:

english

File:

PDF, 1.41 MB

english, 2018

3

Experimental study of electrochemical mass transfer in an annular duct with the electrolyte nanofluid

Wilk, Joanna, Grosicki, Sebastian

Journal:

International Journal of Thermal Sciences

Year:

2018

Language:

english

File:

PDF, 1021 KB

english, 2018

4

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

Mateos, Maria-Victoria, Nahi, Hareth, Legiec, Wojciech, Grosicki, Sebastian, Vorobyev, Vladimir, Spicka, Ivan, Hungria, Vania, Korenkova, Sibirina, Bahlis, Nizar, Flogegard, Max, BladÃ©, Joan, Moreau,

Journal:

The Lancet Haematology

Year:

2020

File:

PDF, 608 KB

2020

5

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Hillmen, Peter, Robak, Tadeusz, Janssens, Ann, Babu, K Govind, Kloczko, Janusz, Grosicki, Sebastian, Doubek, Michael, Panagiotidis, Panagiotis, Kimby, Eva, Schuh, Anna, Pettitt, Andrew R, Boyd, Thomas

Journal:

Year:

2015

Language:

english

File:

PDF, 399 KB

english, 2015

6

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Burger, Jan A., Tedeschi, Alessandra, Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Bartlett, Nancy L., Li, Jianyong, Simpson, David, Grosicki, Sebastian, D

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 567 KB

english, 2015

7

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: A retrospective, multicenter Polish Adult Leukemia Group study

Grosicki, Sebastian, Holowiecki, Jerzy, Kuliczkowski, Kazimierz, Skotnicki, Aleksander, Hellmann, Andrzej, Kyrcz-Krzemien, Slawomira, Dmoszynska, Anna, Sułek, Kazimierz, Kloczko, Janusz, Jedrzejczak,

Journal:

American Journal of Hematology

Year:

2015

Language:

english

File:

PDF, 498 KB

english, 2015

8

Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL

Hillmen, Peter, Janssens, Ann, Babu, K. Govind, Kloczko, Janusz, Grosicki, Sebastian, Manson, Stephanie, McKeown, Astrid, Gupta, Ira, Chang, Chai-Ni, Offner, Fritz

Journal:

Acta Oncologica

Year:

2016

Language:

english

File:

PDF, 1.01 MB

english, 2016

9

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Kipps, Thomas J., Eradat, Herbert, Grosicki, Sebastian, Catalano, John, Cosolo, Walter, Dyagil, Iryna S., Yalamanchili, Sreeni, Chai, Akiko, Sahasranaman, Srikumar, Punnoose, Elizabeth, Hurst, Deborah

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 603 KB

english, 2015

10

Szpiczak plazmocytowy z niewydolnością nerek jako wyzwanie terapeutyczne

Grosicki, Sebastian

Journal:

Acta Haematologica Polonica

Year:

2015

Language:

polish

File:

PDF, 710 KB

polish, 2015

11

Elotuzumab: a novel immune-stimulating therapy to treat multiple myeloma.

Grosicki, Sebastian, Barchnicka, Agnieszka

Journal:

Expert Review of Hematology

Year:

2016

Language:

english

File:

PDF, 616 KB

english, 2016

12

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth

Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San-Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter-Croneck, Ad

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 413 KB

english, 2017

13

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

Tausch, Eugen, Beck, Philipp, Schlenk, Richard F., Jebaraj, Billy J., Dolnik, Anna, Yosifov, Deyan Y., Hillmen, Peter, Offner, Fritz, Janssens, Ann, Babu, K. Govind, Grosicki, Sebastian, Mayer, Jiri,

Journal:

Year:

2020

File:

PDF, 2.09 MB

2020

14

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta, Ewa Wawrzyniak, Barbara Cebula, Jerzy Hołowiecki, Sławomira Kyrcz-Krzemień, Sebastian Grosicki, Sebastian Giebel, Aleksander B. Skotnicki, Beata

Journal:

European Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 259 KB

english, 2008

15

G-CSF Administered in Time-sequenced Setting During Remission Induction and Consolidation Therapy of Adult Acute Lymphoblastic Leukemia has Beneficial Influence on Early Recovery and Possibly Improves Long-term Outcome: A Randomized Multicenter Study

Hołowiecki, Jerzy, Giebel, Sebastian, Krzemień, Sławomira, Krawczyk-Kuliś, Małgorzata, Jagoda, Krystyna, Kopera, Małgorzata, Hołowiecka, Beata, Grosicki, Sebastian, Hellmann, Andrzej, Dmoszyńska, Anna

Journal:

Leukemia and Lymphoma

Year:

2002

Language:

english

File:

PDF, 1.43 MB

english, 2002

16

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Dimopoulos, Meletios A., Grosicki, Sebastian, Jędrzejczak, Wiesław W., Nahi, Hareth, Gruber, Astrid, Hansson, Markus, Gupta, Neeraj, Byrne, Catriona, Labotka, Richard, Teng, Zhaoyang, Yang, Huyuan, Gr

Journal:

European Journal of Cancer

Year:

2019

Language:

english

File:

PDF, 450 KB

english, 2019

17

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Burger, Jan A., Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Tedeschi, Alessandra, Bairey, Osnat, Hillmen, Peter, Coutre, Steven E., Devereux, Stephen, Grosicki, Sebastian, McCarthy, Hel

Journal:

Year:

2019

File:

PDF, 1.78 MB

2019

18

Refeeding syndrome in hematological cancer patients â current approach

Szeja, Nicola, Grosicki, Sebastian

Journal:

Expert Review of Hematology

Year:

2020

File:

PDF, 1.35 MB

2020

19

An Open-label, Phase 2 Study to Evaluate the Oral Combination of Ixazomib, Cyclophosphamide, and Dexamethasone (ICd) in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Dimopoulos, Meletios, Grosicki, Sebastian, Jędrzejczak, Wiesław, Nahi, Hareth, Gruber, Astrid, Hansson, Markus, Byrne, Catriona, Labotka, Richard, Teng, Zhaoyang, Yang, Huyuan, Grzasko, Norbert, Kumar

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 99 KB

english, 2017

20

Exome Sequencing of AL Amyloidosis Reveals Recurrently Mutated Genes

Kufova, Zuzana, Sevcikova, Tereza, Vojta, Petr, Filipova, Jana, Growkova, Katerina, Grosicki, Sebastian, Kryukov, Fedor, Hajek, Roman

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 78 KB

english, 2017

21

Heat shock proteins as a new, promising target of multiple myeloma therapy

Grosicki, Sebastian, Bednarczyk, Martyna, Janikowska, GraÅ¼yna

Journal:

Expert Review of Hematology

Year:

2020

File:

PDF, 1.17 MB

2020

22

Leczenie podtrzymujące w szpiczaku plazmocytowym

Grosicki, Sebastian

Journal:

Acta Haematologica Polonica

Year:

2013

Language:

polish

File:

PDF, 276 KB

polish, 2013

23

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avig

Journal:

Leukemia and Lymphoma

Year:

2020

File:

PDF, 1.45 MB

2020

24

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

van Oers, Marinus, Smolej, Lukas, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Davis, Jaclyn, Banerjee, Hiya, Stefanelli, Tommaso, Hoever, Petra, Geisler, Christian

Journal:

Blood Cancer Journal

Year:

2019

File:

PDF, 1.06 MB

2019

25

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study

Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Weisel, Katja, San-Miguel, Jesus, Shpilberg, Ofer, Grosicki, Sebastian, Å piÄka, Ivan, Walter-Croneck, Adam, Magen, Hila, Mat

Journal:

Blood Cancer Journal

Year:

2020

File:

PDF, 810 KB

2020

26

Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study

Jerzy Hołowiecki, Sebastian Grosicki, Sławomira Kyrcz-Krzemien, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Krzysztof Warzocha, Ilona Seferynska, Barbara Zdziarska

Journal:

Annals of Hematology

Year:

2008

Language:

english

File:

PDF, 206 KB

english, 2008

27

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study

van Oers, Marinus H J, Kuliczkowski, Kazimierz, Smolej, Lukáš, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Gupta, Ira, Phillips, Jennifer, Williams, Vanessa, Manson, Stephan

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 493 KB

english, 2015

28

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Lonial, Sagar, Dimopoulos, Meletios, Palumbo, Antonio, White, Darrell, Grosicki, Sebastian, Spicka, Ivan, Walter-Croneck, Adam, Moreau, Philippe, Mateos, Maria-Victoria, Magen, Hila, Belch, Andrew, Re

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 469 KB

english, 2015

29

Thermophysical properties of water based Cu nanofluid used in special type of coil heat exchanger

Wilk, Joanna, Smusz, Robert, Grosicki, Sebastian

Journal:

Applied Thermal Engineering

Year:

2017

Language:

english

File:

PDF, 1.31 MB

english, 2017

30

Bortezomib for the treatment of multiple myeloma

Grosicki, Sebastian, Barchnicka, Agnieszka, Jurczyszyn, Artur, Grosicka, Anida

Journal:

Expert Review of Hematology

Year:

2014

Language:

english

File:

PDF, 471 KB

english, 2014

31

A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL

Flinn, Ian W., Panayiotidis, Panayiotis, Afanasyev, Boris, Janssens, Ann, Grosicki, Sebastian, Homenda, Wojciech, Smolej, Lukas, Kuliczkowski, Kazimierz, Doubek, Michael, Domnikova, Natalia, West, Sar

Journal:

American Journal of Hematology

Year:

2016

Language:

english

File:

PDF, 1021 KB

english, 2016

32

Phase 2 Study of the All-Oral Combination of Ixazomib Plus Cyclophosphamide and Low-Dose Dexamethasone (ICd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Kumar, Shaji, Grzasko, Norbert, Delimpasi, Sossana, Jędrzejczak, Wieslaw, Grosicki, Sebastian, Kyrtsonis, Marie Christine, Spencer, Andrew, Gupta, Neeraj, Teng, Zhaoyang, Byrne, Catriona, Labotka, Ric

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 62 KB

english, 2017

33

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Chyra, Zuzana, Sevcikova, Tereza, Vojta, Petr, Puterova, Janka, Brozova, Lucie, Growkova, Katerina, Filipova, Jana, Zatopkova, Martina, Grosicki, Sebastian, Barchnicka, Agnieszka, Jedrzejczak, Wieslaw

Journal:

Year:

2020

File:

PDF, 2.96 MB

2020

34

Possibilities of the Use of the Electrolytic Technique for the Investigations of Mass/Heat Transfer in Nanofluid

Grosicki, Sebastian

Journal:

Applied Mechanics and Materials

Year:

2016

Language:

english

File:

PDF, 387 KB

english, 2016

35

A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial

Grosicki, Sebastian, Lech-Maranda, Ewa, Govind Babu, Kanakasetty, Rybka, Justyna, Litvinskaya, Elena, Loscertales, Javier, Kriachok, Iryna, KÅoczko, Janusz, Rekhtman, Grygoriy, Homenda, Wojciech, Blo

Journal:

Leukemia and Lymphoma

Year:

2020

Language:

english

File:

PDF, 867 KB

english, 2020

36

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study

Sebastian Grosicki, Jerzy Holowiecki, Sebastian Giebel, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Andrzej Hellmann, Agniesz

Journal:

American Journal of Hematology

Year:

2011

Language:

english

File:

PDF, 83 KB

english, 2011

37

Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: a cross-trial comparison of phase 3 studies

Robak, Tadeusz, Burger, Jan A., Tedeschi, Alessandra, Barr, Paul M., Owen, Carolyn, Bairey, Osnat, Hillmen, Peter, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, McCarthy, Helen, Coutre, Stev

Journal:

American Journal of Hematology

Year:

2018

Language:

english

File:

PDF, 1.51 MB

english, 2018

38

Elotuzumab plus lenalidomide/dexamethasone for relapsed/refractory multiple myeloma: Final overall survival results from the phase 3 ELOQUENT-2 trial

Dimopoulos, Meletios A., Weisel, Katja, Lonial, Sagar, White, Darrell, Moreau, Philippe, Mateos, Maria-Victoria, San-Miguel, Jesus, Anderson, Kenneth C., Shpilberg, Ofer, Grosicki, Sebastian, Spicka,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 91 KB

2019

39

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

Masternak, Marta, PuÅa, Bartosz, Knap, Joanna, Waszczuk-Gajda, Anna, Drozd-SokoÅowska, Joanna, Wdowiak, Kamil, Grosicki, Sebastian, KozÅowska, Izabela, KaÅºmierczak, Marta, ÅabÄdÅº, Anna, Szukals

Journal:

Cancer Management and Research

Year:

2020

File:

PDF, 1.30 MB

2020

40

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma

Dimopoulos, Meletios A., Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S., Richardson, Paul G., Po

Journal:

New England Journal of Medicine

Year:

2018

Language:

english

File:

PDF, 281 KB

english, 2018

41

Fiveâyear survival followâup of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabineârefractory chronic lymphocytic leukaemia: a short report

Miklos, Udvardy, Strugov, Vladimir, Lewerin, Catharina, Grosicki, Sebastian, Mazur, Grzegorz, Steurer, Michael, Montillo, Marco, Kryachok, Irina, Middeke, Jan M., Rekhtman, Grygoriy, Stefanelli, Tomma

Journal:

British Journal of Haematology

Year:

2020

Language:

english

File:

PDF, 493 KB

english, 2020

42

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

Philippe Moreau, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Maria Grishunina, Grigoriy Rekhtman, Zvenyslava Masliak, Tadeusz Robak, Anna Shubina, Bertrand Arnulf, Martin

Journal:

The Lancet Oncology

Year:

2011

Language:

english

File:

PDF, 247 KB

english, 2011

43

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

Jurczyszyn, Artur, Gozzetti, Alessandro, Gdula-Argasińska, Joanna, Czepiel, Jacek, Vij, Ravi, Fiala, Mark, Valls, Davila Julio, Mądry, Krzysztof, Waszczuk-Gajda, Anna, Grosicki, Sebastian, Barchnicka,

Journal:

Annals of Hematology

Year:

2017

Language:

english

File:

PDF, 415 KB

english, 2017

44

The results of imatinib therapy for patients with primary eosinophilic disorders

Grzegorz Helbig, Beata Stella-Holowiecka, Sebastian Grosicki, Grazyna Bober, Magorzata Krawczyk, Jerzy Wojnar, Andreas Reiter, Andreas Hochhaus, Jerzy Holowiecki

Journal:

European Journal of Haematology

Year:

2006

Language:

english

File:

PDF, 82 KB

english, 2006

45

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial

Mittelman, Moshe, Platzbecker, Uwe, Afanasyev, Boris, Grosicki, Sebastian, Wong, Raymond S M, Anagnostopoulos, Achilles, Brenner, Benjamin, Denzlinger, Claudio, Rossi, Giuseppe, Nagler, Arnon, Garcia-

Journal:

The Lancet Haematology

Year:

2018

Language:

english

File:

PDF, 957 KB

english, 2018

46

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma

Kumar, Shaji K., Grzasko, Norbert, Delimpasi, Sosana, Jedrzejczak, Wieslaw W., Grosicki, Sebastian, Kyrtsonis, Marie-Christine, Spencer, Andrew, Gupta, Neeraj, Teng, Zhaoyang, Byrne, Catriona, Labotka

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 265 KB

english, 2018

47

Secondary Acute Myeloid Leukemia (sAML) Immediately after Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)

Grosicki, Sebastian

Journal:

Journal of Leukemia

Year:

2013

Language:

english

File:

PDF, 407 KB

english, 2013

48

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma

Głowala-Kosińska, Magdalena, Chwieduk, Agata, Nieckula, Jarosław, Saduś-Wojciechowska, Maria, Grosicki, Sebastian, Rusin, Aleksandra, Nowara, Elżbieta, Giebel, Sebastian

Journal:

European Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 234 KB

english, 2013

49

Extended 5-Year Follow-Up of the Phase 3 ELOQUENT-2 Study of Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Versus Ld in Relapsed/Refractory Multiple Myeloma (RRMM)

Lonial, Sagar, Dimopoulos, Meletios, Weisel, Katja, White, Darrell, Moreau, Philippe, Mateos, Maria-Victoria, San Miguel, Jesus, Anderson, Kenneth, Shpilberg, Ofer, Grosicki, Sebastian, Spicka, Ivan,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 66 KB

english, 2018

50

Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia

Burger, Jan, Tedeschi, Alessandra, Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Coutre, Steven E., Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 72 KB

english, 2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски